Rethink your approach to first-line MDD treatments

Are you giving your adult patients living with major depressive disorder the
best chance at remission?

Icon 63 of patients

did not reach remission with the first-line treatment, which was a selective serotonin reuptake inhibitor (SSRI).*

These rates increased with each successive therapy.1

Chart

The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study provided up to 4 treatment steps for MDD patients (N=3671).1

*Remission was defined as a score of ≤5 on the 16-item QIDS-SR.1